Brendan Digan
Stock Analyst at Citi
(2.65)
# 2,881
Out of 5,028 analysts
6
Total ratings
66.7%
Success rate
40.3%
Average return
Main Sectors:
Top Industries:
Stocks Rated by Brendan Digan
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| NTRA Natera | Reiterated: Buy | $315 → $365 | $425.64 | -14.25% | 3 | Aug 14, 2026 | |
| QGEN Qiagen | Reiterated: Hold | $45 | $45.79 | -1.73% | 1 | Aug 10, 2026 | |
| SHC Sotera Health Company | Reiterated: Buy | $25 | $18.55 | +34.77% | 1 | Aug 7, 2026 | |
| TXG 10x Genomics | Reiterated: Hold | $50 | $97.74 | -48.84% | 1 | Aug 7, 2026 |
Natera
Aug 14, 2026
Reiterated: Buy
Price Target: $315 → $365
Current: $425.64
Upside: -14.25%
Qiagen
Aug 10, 2026
Reiterated: Hold
Price Target: $45
Current: $45.79
Upside: -1.73%
Sotera Health Company
Aug 7, 2026
Reiterated: Buy
Price Target: $25
Current: $18.55
Upside: +34.77%
10x Genomics
Aug 7, 2026
Reiterated: Hold
Price Target: $50
Current: $97.74
Upside: -48.84%